ArticleJournal of medical case reports2026
An uncommon case of Chromobacterium violaceum urinary tract infection in a tertiary hospital in Ghana: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChromobacterium violaceum is a facultative, Gram-negative, motile bacillus that rarely causes human infections, but could lead to severe disease with high mortality when systemic spread occurs. Reported infections include bacteremia, septicemia, wound infections, skin lesions, respiratory tract infections, and rarely urinary tract infections. CASE PRESENTATION: We report a rare case of C. violaceum isolated from the urine of a 35-year-old female from the Dagomba ethnic group in the Northern Region of Ghana who presented with a recurrent right flank pain and right upper quadrant abdominal pain at the Tamale Teaching Hospital. The organism was identified through biochemical testing and whole genome sequencing. The infection resolved after two doses of azithromycin (500 mg) and five doses of metronidazole (400 mg).
conclusionHuman infection with Chromobacterium violaceum is extremely rare in Ghana. This case represents the first documented C. violaceum-associated urinary tract infection in the country and provides detailed perspectives into its biochemistry, antimicrobial susceptibility, and genomic characteristics. Greater clinical and laboratory awareness of this pathogen is essential for timely diagnosis and management of similar rare infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.